Dr. Torey Collier, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $987.07 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $226.48 | 12 | $0 (2024) |
| Lilly USA, LLC | $217.91 | 12 | $0 (2024) |
| ABBVIE INC. | $113.55 | 3 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $87.82 | 5 | $0 (2024) |
| Amgen Inc. | $64.40 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $52.75 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $38.97 | 2 | $0 (2024) |
| Exact Sciences Corporation | $36.19 | 2 | $0 (2024) |
| Boston Scientific Corporation | $28.36 | 2 | $0 (2022) |
| UCB, Inc. | $23.47 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $489.24 | 28 | Novo Nordisk Inc ($140.54) |
| 2023 | $294.49 | 13 | AbbVie Inc. ($97.74) |
| 2022 | $136.83 | 8 | Lilly USA, LLC ($51.36) |
| 2021 | $43.04 | 3 | PFIZER INC. ($22.79) |
| 2019 | $23.47 | 1 | UCB, Inc. ($23.47) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Respiratory | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: RESPIRATORY | ||||||
| 06/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Inflammation | ||||||
| 05/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Obesity | ||||||
| 05/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Obesity | ||||||
| 04/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/08/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Diabetes | ||||||
| 03/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Diabetes | ||||||
| 03/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 880 | 1,411 | $95,757 | $49,686 |
| 2022 | 15 | 539 | 667 | $44,096 | $23,279 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 286 | $40,040 | $23,842 | 59.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 182 | $17,472 | $9,432 | 54.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 55 | 65 | $8,905 | $3,389 | 38.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 28 | 28 | $4,452 | $3,284 | 73.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $3,360 | $2,392 | 71.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $2,068 | $1,335 | 64.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 75 | 119 | $1,012 | $936.64 | 92.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 37 | 45 | $1,890 | $729.00 | 38.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 58 | 76 | $2,660 | $663.12 | 24.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 52 | 64 | $3,776 | $662.40 | 17.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 34 | 36 | $540.00 | $529.20 | 98.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 51 | 68 | $2,040 | $517.48 | 25.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 36 | $504.00 | $493.92 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 44 | $1,804 | $418.88 | 23.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 27 | 27 | $1,404 | $354.24 | 25.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 17 | 21 | $1,218 | $296.94 | 24.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 23 | 28 | $1,316 | $232.12 | 17.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 50 | 77 | $924.00 | $163.12 | 17.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 39 | 186 | $372.00 | $16.11 | 4.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 112 | $15,680 | $10,300 | 65.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 121 | $11,616 | $8,310 | 71.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 48 | 51 | $6,987 | $1,516 | 21.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 34 | 34 | $510.00 | $499.80 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 33 | $462.00 | $452.76 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 35 | 39 | $1,365 | $390.64 | 28.6% |
About Dr. Torey Collier, MD
Dr. Torey Collier, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Houston, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2019. The National Provider Identifier (NPI) number assigned to this provider is 1700446358.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Torey Collier, MD has received a total of $987.07 in payments from pharmaceutical and medical device companies, with $489.24 received in 2024. These payments were reported across 53 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($987.07).
As a Medicare-enrolled provider, Collier has provided services to 1,419 Medicare beneficiaries, totaling 2,078 services with total Medicare billing of $72,964. Data is available for 2 years (2022–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Houston, MS
- Active Since 06/17/2019
- Last Updated 12/01/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1700446358
Products in Payments
- MOUNJARO (Drug) $199.13
- Ozempic (Drug) $153.93
- VRAYLAR (Drug) $113.55
- VOQUEZNA (Drug) $87.82
- Rybelsus (Drug) $61.37
- BREZTRI (Drug) $52.75
- Otezla (Drug) $47.49
- Cologuard Collection Kit (Device) $36.19
- General - Pain Management (Device) $28.36
- Briviact (Drug) $23.47
- GVOKE HYPOPEN (Drug) $23.13
- ELIQUIS (Drug) $22.79
- SHINGRIX (Biological) $20.25
- OFEV (Drug) $19.61
- ZEPBOUND (Drug) $18.78
- TRELEGY ELLIPTA (Drug) $18.72
- Repatha (Biological) $16.91
- Xhance (Drug) $16.67
- YUPELRI (Drug) $14.97
- Wegovy (Drug) $11.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Houston
Sandeep Sahay, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $366,850
Diego Marines Copado, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $287,975
Dr. Eddie Patton, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $235,342
Naveen Pemmaraju, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $198,556
Laila Tabatabai, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $194,524
Syed Naqvi, M.d./M.b.a, M.D./M.B.A
Student in an Organized Health Care Education/Training Program — Payments: $144,401